Ultra High Field MR for Patients with Neurological and Musculoskeletal Disease: Phase II Improved Imaging and Contrast Mechanisms Using the MR950 Platform
Sponsor: General Electric Company
Location(s): United States
The goal of this project is to obtain MR imaging data from patients using the 7T whole body scanner in the Surbeck Laboratory. The subjects will include individuals for whom the assessment of disease severity and treatment response have been challenging using conventional imaging methods. Population that have been identified as being of interest are patients with psychiatric diseases, Multiple Sclerosis, radiation injury or osteoarthritis.